In the last trading session, 2.03 million Klotho Neurosciences Inc (NASDAQ:KLTO) shares changed hands as the company’s beta touched 2.57. With the company’s per share price at $1.2 changed hands at -$0.09 or -6.98% during last session, the market valuation stood at $63.24M. KLTO’s last price was a discount, traded about -225.83% off its 52-week high of $3.91. The share price had its 52-week low at $0.11, which suggests the last value was 90.83% up since then. When we look at Klotho Neurosciences Inc’s average trading volume, we note the 10-day average is 9.98 million shares, with the 3-month average coming to 43.21 million.

Klotho Neurosciences Inc (NASDAQ:KLTO) trade information

Instantly KLTO was in red as seen at the end of in last trading. With action -4.00%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -25.47%, with the 5-day performance at -4.00% in the red. However, in the 30-day time frame, Klotho Neurosciences Inc (NASDAQ:KLTO) is -20.00% down. Looking at the short shares, we see there were 2.67 million shares sold at short interest cover period of 0.05 days.

Klotho Neurosciences Inc (NASDAQ:KLTO)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 50.23% of Klotho Neurosciences Inc shares while 2.60% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 5.23%.

Among Mutual Funds, the top two as of May 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund. With 90.06 shares estimated at $0.11 million under it, the former controlled 0.20% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.05% of the shares, roughly 21.4 shares worth around $25678.0.